Heartflow (HTFL) FCF Margin (2024 - 2025)
Heartflow (HTFL) recorded quarterly FCF Margin of 25.43% in Q4 2025, down 180.75% quarter-over-quarter from 9.06% in Q3 2025, and up 1565.0% on a YoY basis from 1.53% in Q4 2024.
Heartflow (HTFL) FCF Margin (2024 - 2025) Analysis & Trends
Heartflow's FCF Margin history runs 2 years deep, the most recent figure standing at 25.43% for Q4 2025.
- In Q4 2025, FCF Margin rose 1565.0% year-over-year to 25.43%; the TTM figure through Dec 2025 stood at 17.87% (changed N/A YoY), while the FY2025 annual figure was 33.54%, up 2477.0% from the prior year.
- FCF Margin was 25.43% for Q4 2025 at Heartflow, down from 9.06% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 9.06% in Q3 2025 to a low of 41.08% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 127.46% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.30% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 23.01% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 23.62% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 17.24% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 73.79% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 22.17% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -8.19% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 13.57% |
| 10 | Heartflow | 1.24 Bn | 1.06 Bn | 39.06 Mn | -25.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.43% |
| Sep 30, 2025 | -9.06% |
| Dec 31, 2024 | -41.08% |
| Sep 30, 2024 | -34.27% |